SCHEMBL24710359

SCHEMBL24710359

CC(C)[C@H](C)CC[C@@H](C)[C@H]1CCC2[C@@H]3CCC4C[C@@H](O)CC[C@]4(C)C3CC[C@@]21C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 7/20 0.72
▸ EPHA2 P29317 4/20 0.72
▸ CASP7 P55210 3/20 0.72
▸ HIF1A Q16665 3/20 0.72
▸ TP53 P04637 2/20 0.72
▸ MAPK1 P28482 2/20 0.72
▸ HSD17B10 Q99714 2/20 0.72
▸ BLM P54132 2/20 0.72
▸ TDP1 Q9NUW8 2/20 0.72
▸ VDR P11473 2/20 0.72
▸ USP2 O75604 2/20 0.72
▸ LMNA P02545 2/20 0.72
▸ CYP3A4 P08684 2/20 0.72
▸ MDM4 O15151 1/20 0.72
▸ MAPT P10636 1/20 0.72
▸ HSPD1 P10809 1/20 0.72
▸ TSHR P16473 1/20 0.72
▸ PTPN2 P17706 1/20 0.72
▸ PTPN1 P18031 1/20 0.72
▸ BRCA1 P38398 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14116859 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL480834 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL13988148 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL167700 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL14612012 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL14537828 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL15346202 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL21748184 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL21524957 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53
SCHEMBL14350523 1.00 GPBAR1 (0.72) GPBAR1EPHA2CASP7HIF1ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261510-A1 NEUROACTIVE STEROID FOR THE TREATMENT OF ALZHEIMER'S DISEASE SAGE THERAPEUTICS, INC. (US) 2022-12-15 — — WO disclosed
Send feedback